Foghorn Therapeutics Inc. Earnings Per Share, Basic and Diluted
Foghorn Therapeutics Inc. (FHTX) reported Earnings Per Share, Basic and Diluted of -$0.62 per share for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-11.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2021-05-11
- Foghorn Therapeutics Inc. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.62.
- Foghorn Therapeutics Inc. earnings per share, basic and diluted for the quarter ending 2020-12-31 was -$0.75.
- Foghorn Therapeutics Inc. earnings per share, basic and diluted for the quarter ending 2020-09-30 was -$3.12.
- Foghorn Therapeutics Inc. earnings per share, basic and diluted for the quarter ending 2020-03-31 was -$2.71.
- Foghorn Therapeutics Inc. earnings per share, basic and diluted for fiscal 2020 was -$6.23.
- Foghorn Therapeutics Inc. earnings per share, basic and diluted for fiscal 2019 was -$12.20.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2021-03-31 | -$0.62 10-Q · filed 2021-05-11 | -$1.36 derived: net income ÷ weighted average shares · filed 2022-11-08 | -$2.65 derived: net income ÷ weighted average shares · filed 2022-11-08 | |
| 2020-12-31 | -$0.75 derived: net income ÷ weighted average shares · filed 2022-08-09 | -$2.33 derived: net income ÷ weighted average shares · filed 2022-08-09 | -$6.23 10-K · filed 2021-03-18 | |
| 2020-09-30 | -$3.12 10-Q · filed 2020-12-04 | -$8.76 10-Q · filed 2020-12-04 | ||
| 2020-03-31 | -$2.71 10-Q · filed 2021-05-11 | -$5.90 derived: net income ÷ weighted average shares · filed 2021-11-09 | -$8.94 derived: net income ÷ weighted average shares · filed 2021-11-09 | |
| 2019-12-31 | -$3.21 derived: net income ÷ weighted average shares · filed 2021-03-18 | -$6.27 derived: net income ÷ weighted average shares · filed 2021-03-18 | -$12.20 10-K · filed 2021-03-18 | |
| 2019-09-30 | -$3.05 10-Q · filed 2020-12-04 | -$8.96 10-Q · filed 2020-12-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |